 |
 |

Treatment Strategy for Intraductal Papillary Mucinous Neoplasm of the Pancreas Based on Malignant Predictive Factors—Invited Critique
David B. Adams, MD
Arch Surg. 2009;144(4):349-350.
 |
 |
| Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings. |
|
 |
 |
The Nobel physicist Sir Ernest Rutherford said, "all science is either physics or stamp collecting."1 It is difficult to realize that surgical science is frequently closer to stamp collecting than to physics. We examine information from our collection of patients and try to define disease on the basis of the data at hand. Much is missing from the record, and we overcome this with a variety of statistical tools and insightful leaps of imagination. The question goes begging, "What do we know about what we do not know?" With IPMN we constantly need to remind ourselves that there is much we do not know. The conventional wisdom is that branch-duct IPMNs are less aggressive than main-duct IPMNs, malignancy is more common in older patients, malignancy is found in about 70% of resected main-duct IPMNs, recurrence is rare after resection of noninvasive IPMNs, and recurrence occurs in . . . [Full Text of this Article]
CiteULike Connotea Del.icio.us Digg Reddit Technorati Twitter
What's this?
RELATED ARTICLE
Treatment Strategy for Intraductal Papillary Mucinous Neoplasm of the Pancreas Based on Malignant Predictive Factors
Seiko Hirono, Masaji Tani, Manabu Kawai, Shinomi Ina, Ryohei Nishioka, Motoki Miyazawa, Yoichi Fujita, Kazuhisa Uchiyama, and Hiroki Yamaue
Arch Surg. 2009;144(4):345-349.
ABSTRACT
| FULL TEXT
|